CONFERENCES

      Tobacco and Nicotine Product Regulatory Science Symposium

      Date
      Mar 30, 2023 - Mar 30, 2023
      Location
      Washington DC, USA/Virtual

      The Food and Drug Law Institue, FDLI, hosts this symposium, which provides a forum for various stakeholders to share their research studies on a wide range of disciplines related to tobacco and nicotine product regulatory science. Presentations at this symposium will be critiqued and discussed by expert panelists, in addition to the opportunity for constructive dialog between the speakers and audience.

      Go to conference: https://www.fdli.org/2023/03/tobacco-and-nicotine-product-regulatory-science-symposium/

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.